CUSHING'S SYNDROME
Clinical trials for CUSHING'S SYNDROME explained in plain language.
Never miss a new study
Get alerted when new CUSHING'S SYNDROME trials appear
Sign up with your email to follow new studies for CUSHING'S SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New PET scans may unmask hidden tumors in rare hormone disorder
Diagnosis Recruiting nowThis study tests whether newer PET scans (68Ga-DOTATATE and F-DOPA) can better locate the hidden tumors that cause ectopic Cushing syndrome, a rare condition where the body makes too much cortisol. About 80 adults aged 18-90 with this condition will receive these scans along with…
Matched conditions: CUSHING'S SYNDROME
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Diagnosis
Last updated May 17, 2026 02:46 UTC
-
New PET scan could pinpoint Hard-to-Diagnose Cushing's subtypes
Diagnosis Recruiting nowThis study is testing a new type of PET scan (68Ga-Pentixafor) to see if it can better tell apart two main types of Cushing's syndrome and find hidden tumors. Researchers will scan 160 adults with suspected or confirmed Cushing's. The goal is to improve diagnosis accuracy compare…
Matched conditions: CUSHING'S SYNDROME
Phase: PHASE1, PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Diagnosis
Last updated May 17, 2026 02:43 UTC
-
New PET tracer could reveal hidden Hormone-Making tumors
Diagnosis Recruiting nowThis study tests a radioactive tracer called [68Ga]Ga-PentixaFor to see if it can better identify adrenal tumors that release extra hormones. About 80 adults with high aldosterone or cortisol levels and at least one adrenal tumor will get one PET scan with the tracer. The goal is…
Matched conditions: CUSHING'S SYNDROME
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Diagnosis
Last updated May 15, 2026 11:53 UTC